Drug addiction: Pathways to the disease and pathophysiological perspectives

European Neuropsychopharmacology

Volumn 17, Issue 6-7, 2007, Pages 377-393

  Le Moal, Michel ^a   Koob, George F ^b  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Definition physiopathology; Drug addiction

Indexed keywords

COCAINE; DIAMORPHINE; OPIATE; PSYCHOSTIMULANT AGENT;

BRAIN DYSFUNCTION; BRAIN REGION; CHRONIC DISEASE; COMORBIDITY; COMPULSION; DRUG DEPENDENCE; HUMAN; IMPULSE CONTROL DISORDER; LIFE EVENT; MOOD DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELAPSE; REVIEW; STRESS; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

HUMANS; REINFORCEMENT (PSYCHOLOGY); RESEARCH; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 33947683824     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2006.10.006     Document Type: Review

References (143)

1. Ahmed S.H., and Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282 (1998) 298-300
2. Ahmed S.H., Kenny P.J., Koob G.F., and Markou A. Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat. Neurosci. 5 (2002) 625-626
3. American Psychiatric Association. Diagnostic Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington DC.
4. Arnsten A.F., and Li B.M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol. Psychiatry 57 (2005) 1377-1384
5. Aston-Jones G., and Harris G.C. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47 Suppl 1 (2004) 167-179
6. Aston-Jones G., Delfs J.M., Druhan J., and Zhu Y. The bed nucleus of the stria terminalis: a target site for noradrenergic actions in opiate withdrawal. In: McGinty J.F. (Ed). Advancing from the Ventral Striatum to the Extended Amygdala: Implications for Neuropsychaitry and Drug Abuse. Annals of the New York Academy of Sciences (1999), Academy of Sciences, New York 486-498
7. Aytaclar S., Tarter R.E., Kirisci L., and Lu S. Association between hyperactivity and executive cognitive functioning in childhood and substance use in early adolescence. J. Am. Acad. Child Adolesc. Psych. 38 (1999) 172-178
8. Barrot M., Marinelli M., Abrous D.N., Rougé-Pont F., Le Moal M., and Piazza P.V. The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur. J. Neurosci. 12 (2000) 973-979
9. Bartlett E., Hallin A., Chapman B., and Angrist B. Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability?. Neuropsychopharmacology 16 (1997) 77-82
10. Baumeister R.F., Heatherton T.F., and Tice D.M. Losing Control: How and Why People Fail at Self-Regulation (1994), Academic Press, San Diego
11. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 8 (2005) 1458-1463
12. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 28 (1998) 309-369
13. Breiter H.C., Gollub R.L., Weisskoff R.M., Kennedy D.N., Makris N., Berke J.D., Goodman J.M., Kantor H.L., Gastfriend D.R., Riorden J.P., Mathew R.T., Rosen B.R., and Hyman S.E. Acute effects of cocaine on human brain activity and emotion. Neuron 19 (1997) 591-611
14. Caine S.B. Cocaine abuse: hard knocks for the dopamine hypothesis?. Nat. Neurosci. 1 (1998) 90-92
15. Cardinal R.N., Parkinson J.A., Hall J., and Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci. Biobehav. Rev. 26 (2002) 321-352
16. Célérier E., Laulin J.P., Corcuff J.B., Le Moal M., and Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J. Neurosci. 21 (2001) 4074-4080
17. Chassin L., Presson C.C., Sherman S.J., and Edwards D.A. The natural history of cigarette smoking: predicting young-adult smoking outcomes from adolescent smoking patterns. Health Psychol. 9 (1990) 701-716
18. Contarino A., Zanotti A., Drago F., Natolino F., Lipartiti M., and Giusti P. Conditioned place preference: no tolerance to the rewarding properties of morphine. Naunyn-Schmiedeberg's Arch. Pharmacol. 355 (1997) 589-594
19. Covington III H.E., and Miczek K.A. Repeated social-defeat stress, cocaine or morphine. Effects on behavioral sensitization and intravenous cocaine self-administration "binges". Psychopharmacology 158 (2001) 388-398
20. Crowley T.J., Macdonald M.J., Whitmore E.A., and Mikulich S.K. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend. 50 (1998) 27-37
21. D'Amato M.R. Derived motives. Ann. Rev. Psychol. 25 (1974) 83-106
22. Dalley J.W., Cardinal R.N., and Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci. Biobehav. Rev. 28 (2004) 771-784
23. Dawes M.A., Tarter R.E., and Kirisci L. Behavioral self-regulation: correlates and 2 year follow-ups for boys at risk for substance abuse. Drug Alcohol Depend. 45 (1997) 165-176
24. de Wit H., Uhlenhuth E.H., and Johanson C.E. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend. 16 (1986) 341-360
25. Delfs J.M., Zhu Y., Druhan J.P., and Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403 (2000) 430-434
26. Deminière J.M., Piazza P.V., Guegan G., Abrous N., Maccari S., Le Moal M., and Simon H. Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Res. 586 (1992) 135-139
27. Deroche V., Le Moal M., and Piazza P.V. Cocaine self-administration increases the incentive motivational properties of the drug in rats. Eur. J. Neurosci. 11 (1999) 2731-2736
28. Deroche-Gamonet V., Belin D., and Piazza P.V. Evidence for addiction-like behavior in the rat. Science 305 (2004) 1014-1017
29. Eddy N.B., Halbach H., Isbell H., and Seevers M.H. Drug dependence: its significance and characteristics. Bull. World Health Organ. 32 (1965) 721-733
30. Erb S., and Stewart J. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J. Neurosci. 19 (1999) RC35
31. Erb S., Hitchcott P.K., Rajabi H., Mueller D., Shaham Y., and Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23 (2000) 138-150
32. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8 (2005) 1481-1489
33. Gaiardi M., Bartoletti M., Bacchi A., Gubellini C., Costa M., and Babbini M. Role of repeated exposure to morphine in determining its affective properties: place and taste conditioning studies in rats. Psychopharmacology 103 (1991) 183-186
34. Giancola P.R., Moss H.B., Martin C.S., Kirisci L., and Tarter R.E. Executive cognitive functioning predicts reactive aggression in boys at high risk for substance abuse: a prospective study. Alcohol Clin. Exp. Res. 20 (1996) 740-744
35. Glantz M.D. Drug Abuse: Origins Abuse: Origins and Interventions (1999), American Psychological Association, Washington DC
36. Glantz M.D., and Pickens R.W. Vulnerability to Drug Abuse (1992), American Psychological Association, Washington DC
37. Goeders N.E. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22 (1997) 237-259
38. Goeders N.E. Stress and cocaine addiction. J. Pharmacol. Exp. Ther. 301 (2002) 785-789
39. Grant B.F., and Dawson D.A. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J. Subst. Abuse 10 (1998) 163-173
40. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., and Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 61 (2004) 1107-1115
41. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., and Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 61 (2004) 807-816
42. Harfstrand A., Fuxe K., Cintra A., Agnati L.F., Zini I., Wikstrom A.C., Okret S., Yu Z.Y., Goldstein M., Steinbusch H., et al. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 9779-9783
43. Harris G.C., and Aston-Jones G. Enhanced morphine preference following prolonged abstinence: association with increased Fos expression in the extended amygdala. Neuropsychopharmacology 28 (2003) 292-299
44. Heilig M., Koob G.F., Ekman R., and Britton K.T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 17 (1994) 80-85
45. Himmelsbach C.K. Can the euphoric, analgetic and physical dependence effects of drugs be separated? IV. With reference to physical dependence. Fed. Proceed. 2 (1943) 201-203
46. Hingson R., Heeren T., Zakocs R., Winter M., and Wechsler H. Age of first intoxication, heavy drinking, driving after drinking and risk of unintentional injury among U.S. college students. J. Stud. Alcohol 64 (2003) 23-31
47. Hoffman H.S., and Solomon R.L. An opponent-process theory of motivation. III. Some affective dynamics in imprinting. Learn. Motivation 5 (1974) 149-164
48. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29 (2006) 568-598
49. Kalivas P.W., and Duffy P. Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J. Neurochem. 50 (1988) 1498-1504
50. Kalivas P.W., and Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13 (1993) 266-275
51. Kandel D.B., and Jessor R. The gateway hypothesis revisited. In: Kandel D.B. (Ed). Stages and pathways of drugs involvement: examining the gateway hypothesis (2002), Cambridge University Press, New York 365-372
52. Karkowski L.M., Prescott C.A., and Kendler K.S. Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs. Am. J. Med. Genet. 96 (2000) 665-670
53. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci. Biobehav. Rev. 27 (2004) 765-776
54. Kenny P.J., Polis I., Koob G.F., and Markou A. Low dose cocaine self-administration transiently increases but high dose cocaine persistently decreases brain reward function in rats. Eur. J. Neurosci. 17 (2003) 191-195
55. Khantzian E.J. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry 142 (1985) 1259-1264
56. Khantzian E.J. Self-regulation and self-medication factors in alcoholism and the addictions: similarities and differences. In: Galanter M. (Ed). Combined alcohol and other drug dependence (1990), Plenum Press, New York 255-271
57. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry 4 (1997) 231-244
58. Kolta M.G., Shreve P., De Souza V., and Uretsky N.J. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24 (1985) 823-829
59. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry 46 (1999) 1167-1180
60. Koob G.F., and Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 242 (1988) 715-723
61. Koob G.F., and Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 278 (1997) 52-58
62. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
63. Koob G.F., and Le Moal M. Drug addiction and allostasis. In: Schulkin J. (Ed). Allostasis, homeostais and the costs of physiological adaptation (2004), Cambridge University Press, New York 150-163
64. Koob G.F., and Le Moal M. Neurobiology of Addiction (2005), Elsevier 570 pp.
65. Koob G.F., and Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 8 (2005) 1442-1444
66. Kreek M.J., and Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 51 (1998) 23-47
67. Larcher A., Laulin J.P., Célérier E., Le Moal M., and Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-methyl-d-aspartate-dependent pain facilitatory systems. Neuroscience 84 (1998) 583-589
68. Laulin J.P., Larcher A., Célérier E., Le Moal M., and Simonnet G. Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur. J. Neurosci. 10 (1998) 782-785
69. Laulin J.P., Célérier E., Larcher A., Le Moal M., and Simonnet G. Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89 (1999) 631-636
70. Laviolette S.R., and van der Kooy D. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol. Psychiatry 8 (2003) 50-59
71. Le Moal M., Stinus L., and Simon H. Increased sensitivity to (+)amphetamine self-administered by rats following meso-cortico-limbic dopamine neurone destruction. Nature 280 (1979) 156-158
72. Leri F., Flores J., Rodaros D., and Stewart J. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J. Neurosci. 22 (2002) 5713-5718
73. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology 98 (1989) 357-362
74. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res. Brain Res. Rev. 30 (1999) 289-304
75. Mao J., Price D.D., and Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14 (1994) 2301-2312
76. Mao J., Sung B., Ji R.R., and Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 22 (2002) 8312-8323
77. Markou A., and Koob G.F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4 (1991) 17-26
78. Martin W.R. A homeostatic and redundancy theory of tolerance to and dependence on narcotic analgesics. In: Wikler A. (Ed). The Addictive States (1968), Williams and Wilkins, Baltimore 206-225
79. Martin W.R., and Eades C.G. A comparative study of the effect of drugs on activating and vasomotor responses evoked by midbrain stimulation: atropine, pentobarbital, chlorpromazine and chlorpromazine sulfoxide. Psychopharmacologia 1 (1960) 303-335
80. McLellan A.T., Woody G.E., Metzger D., McKay J., Durrell J., Alterman A.I., and O'Brien C.P. Evaluating the effectiveness of addiction treatments: reasonable expectations, appropriate comparisons. Milbank Q. 74 (1996) 51-85
81. McLellan A.T., Lewis D.C., O'Brien C.P., and Kleber H.D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284 (2000) 1689-1695
82. Merikangas K.R., Mehta R.L., Molnar B.E., Walters E.E., Swendsen J.D., Aguilar-Gaziola S., Bijl R., Borges G., Caraveo-Anduaga J.J., DeWit D.J., Kolody B., Vega W.A., Wittchen H.U., and Kessler R.C. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav. 23 (1998) 893-907
83. Meyer R.E. The disease called addiction: emerging evidence in a 200-year debate. Lancet 347 (1996) 162-166
84. Miller E.K., and Cohen J.D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 24 (2001) 167-202
85. Mogenson G.J., Jones D.L., and Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 14 (1980) 69-97
86. Nelson J.E., Pearson H.W., Sayers M., and Glynn T.J. In: Nelson J.E., Pearson H.W., Sayers M., and Glynn T.J. (Eds). Guide to Drug Abuse Research Terminology (1982), National Institute on Drug Abuse, Rockville MD
87. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2 (2001) 119-128
88. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25 (2004) 210-218
89. O'Brien C.P., and McLellan A.T. Myths about the treatment of addiction. Lancet 347 (1996) 237-240
90. O'Brien C.P., Ternes J.M., and Ehrman R.N. In: Kalivas P.W., and Samson H.H. (Eds). Classical Conditioning in Human Drug Dependence (1987), Academic Press, Orlando 329-356
91. O'Brien C.P., Volkow N., and Li T.K. What's in a word? Addiction versus dependence in DSM-V. Am. J. Psychiatry 163 (2006) 764-765
92. Olson V.G., Heusner C.L., Bland R.J., During M.J., Weinshenker D., and Palmiter R.D. Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science 311 (2006) 1017-1020
93. Parsons L.H., and Justice Jr. J.B. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61 (1993) 1611-1619
94. Pettit H.O., Ettenberg A., Bloom F.E., and Koob G.F. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84 (1984) 167-173
95. Piazza P.V., and Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 359-378
96. Piazza P.V., and Le Moal M. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res. Brain Res. Rev. 25 (1997) 359-372
97. Piazza P.V., and Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19 (1998) 67-74
98. Piazza P.V., Maccari S., Deminière J.M., Le Moal M., Mormède P., and Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2088-2092
99. Piazza P.V., Rougé-Pont F., Deminière J.M., Kharouby M., Le Moal M., and Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567 (1991) 169-174
100. Piazza P.V., Deroche V., Deminière J.M., Maccari S., Le Moal M., and Simon H. Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11738-11742
101. Piazza P.V., Rougé-Pont F., Deroche V., Maccari S., Simon H., and Le Moal M. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 8716-8720
102. Piazza P.V., Deroche-Gamonet V., Rougé-Pont F., and Le Moal M. Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J. Neurosci. 20 (2000) 4226-4232
103. Pierce R.C., and Kalivas P.W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275 (1995) 1019-1029
104. Pierce R.C., and Kalivas P.W. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 17 (1997) 3254-3261
105. Pierce R.C., and Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci. Biobehav. Rev. 30 (2006) 215-238
106. Poulos C.X., and Cappell H. Homeostatic theory of drug tolerance: a general model of physiological adaptation. Psychol. Rev. 98 (1991) 390-408
107. Rassnick S., Pulvirenti L., and Koob G.F. SDZ-205,152, a novel dopamine receptor agonist, reduces oral ethanol self-administration in rats. Alcohol 10 (1993) 127-132
108. Rassnick S., Stinus L., and Koob G.F. The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res. 623 (1993) 16-24
109. Rivier C., and Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422 (1987) 403-406
110. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18 (1993) 247-291
111. Robinson T.E., and Berridge K.C. Addiction. Annu. Rev. Psychol. 54 (2003) 25-53
112. Robinson T.E., Becker J.B., and Presty S.K. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res. 253 (1982) 231-241
113. Robinson T.E., Becker J.B., Moore C.J., Castaneda E., and Mittleman G. Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis. Brain Res. 343 (1985) 374-377
114. Robinson T.E., Jurson P.A., Bennett J.A., and Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462 (1988) 211-222
115. Russell M.A.H. What is dependence?. In: Edwards G. (Ed). Drugs and Drug Dependence (1976), Lexington Books, Lexington MA 293-300
116. Salamone J.D., Correa M., Mingote S.M., and Weber S.M. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr. Opin. Pharmacol. 5 (2005) 34-41
117. Sato M., Chen C.C., Akiyama K., and Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol. Psychiatry 18 (1983) 429-440
118. Sax K.W., and Strakowski S.M. Behavioral sensitization in humans. J. Addict. Dis. 20 (2001) 55-65
119. Schultz W. Multiple reward signals in the brain. Nat. Rev. Neurosci. 1 (2000) 199-207
120. Schultz W. Getting formal with dopamine and reward. Neuron 36 (2002) 241-263
121. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.D., and Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J. Neurosci. 17 (1997) 2605-2614
122. Shaham Y., Erb S., Leung S., Buczek Y., and Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology 137 (1998) 184-190
123. Shaham Y., Erb S., and Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Brain Res. Rev. 33 (2000) 13-33
124. Shalev U., Grimm J.W., and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol. Rev. 54 (2002) 1-42
125. Shippenberg T.S., Heidbreder C., and Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur. J. Pharmacol. 299 (1996) 33-39
126. Siegel S. Evidence from rats that morphine tolerance is a learned response. J. Comp. Physiol. Psychol. 89 (1975) 498-506
127. Sifneos P.E. Alexithymia, clinical issues, politics and crime. Psychother. Psychosom. 69 (2000) 113-116
128. Solomon R.L. The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am. Psychol. 35 (1980) 691-712
129. Solomon R.L., and Corbit J.D. An opponent-process theory of motivation. II. Cigarette addiction. J. Abnorm. Psychol. 81 (1973) 158-171
130. Solomon R.L., and Corbit J.D. An opponent-process theory of motivation: I. Temporal dynamics of affect. Psychol. Rev. 81 (1974) 119-145
131. Stinus L., Cador M., Zorrilla E.P., and Koob G.F. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology 30 (2005) 90-98
132. Strakowski S.M., Sax K.W., Setters M.J., and Keck Jr. P.E. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol. Psychiatry 40 (1996) 872-880
133. Substance Abuse and Mental Heath Services Administration. Results from the 2002 National Survey on Drug Use and Health: National Findings. Rockville MD (2003)
134. Uhl G.R., and Grow R.W. The burden of complex genetics in brain disorders. Arch. Gen. Psychiatry 61 (2004) 223-229
135. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., and Koob G.F. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin. Exp. Res. 26 (2002) 1494-1501
136. Valdez G.R., Zorrilla E.P., Rivier J., Vale W.W., and Koob G.F. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res. 980 (2003) 206-212
137. Van Dyke C., and Byck R. Cocaine. Sci. Am. 246 (1982) 128-141
138. Vanderschuren L.J., and Everitt B.J. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305 (2004) 1017-1019
139. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151 (2000) 99-120
140. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., and Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386 (1997) 830-833
141. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., Jayne M., Ma Y., and Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci. 26 (2006) 6583-6588
142. Wachtel S.R., and de Wit H. Subjective and behavioral effects of repeated d-amphetamine in humans. Behav. Pharmacol. 10 (1999) 271-281
143. Wolf M.E., White F.J., Nassar R., Brooderson R.J., and Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264 (1993) 249-255